SRX Global completes $3.5M additional closing of private placement, total $8M raised

SRx Health Solutions, Inc.

On July 27, 2026, issued 4,340 Series B Preferred shares and 284,156 Warrants for $3.472M.
Combined with March 16 closing, total proceeds $8.0M from 10,000 Series B Preferred shares and Warrants.
Warrant count reflects 60-for-1 reverse stock split effective July 2, 2026.
Securities sold under Section 4(a)(2) and Rule 506; not registered.
8-K/A corrects prior filing: CFO Carolina Martinez was misidentified as CEO.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.